A 24-year-old unmarried woman from Mumbai presents with primary infertility (married 2 years, regular unprotected intercourse). She reports menarche at age 12 with irregular cycles since onset, occurring every 40–60 days. She denies hirsutism or acne but has gained 8 kg over the past 2 years despite no change in diet. On examination, BMI is 26 kg/m², and there is no clinical hyperandrogenism. Pelvic ultrasound reveals multiple follicles (5–9 mm) bilaterally with normal stromal volume and ovarian volume of 9 cm³ each. Hormonal profile: FSH 6 mIU/mL, LH 8 mIU/mL, free testosterone 2.5 pg/mL (normal), prolactin 18 ng/mL (normal), TSH 2.1 mIU/L (normal). What is the most likely diagnosis?

Explanation

## Clinical Analysis **Key Point:** This patient **meets Rotterdam criteria for PCOD** with 2 out of 3 required criteria present. ## Rotterdam Criteria for PCOD (Requires ≥2 of 3) | Criterion | Present in This Patient? | |---|---| | Oligo/anovulation (cycles >35 days) | **Yes** — cycles every 40–60 days since menarche | | Clinical or biochemical hyperandrogenism | **No** — no hirsutism, acne; normal free testosterone | | Polycystic ovaries on ultrasound | **Yes** — multiple follicles (5–9 mm) bilaterally | **High-Yield:** Under the 2003 Rotterdam consensus, PCOD is diagnosed when **any 2 of 3** criteria are fulfilled. This patient satisfies criterion 1 (oligo-ovulation) and criterion 3 (polycystic ovarian morphology on ultrasound), which is sufficient for diagnosis — hyperandrogenism is NOT required. ## Ultrasound Interpretation The original explanation incorrectly states "normal ovarian morphology." Per Rotterdam criteria, polycystic ovarian morphology is defined as **≥12 follicles measuring 2–9 mm in diameter** in at least one ovary, **OR** ovarian volume >10 cm³. This patient has multiple follicles (5–9 mm) bilaterally — satisfying the follicle count criterion — even though ovarian volume (9 cm³) is just below the 10 cm³ threshold. The presence of multiple small follicles bilaterally constitutes polycystic ovarian morphology per Rotterdam. ## Why Other Diagnoses Are Excluded **Ovulatory Dysfunction without PCOD (Option B):** - Incorrect — the patient meets 2 Rotterdam criteria (oligo-ovulation + polycystic morphology), so PCOD is the correct diagnosis, not non-specific ovulatory dysfunction. **Hypothalamic Amenorrhea (Option C):** - Typically presents with secondary amenorrhea, low/normal-low gonadotropins, and a history of stress, weight loss, or excessive exercise. - This patient has oligomenorrhea since menarche (not secondary), normal FSH/LH, and no precipitating factors. **Normgonadotropic Hypogonadism (Option A):** - Not a standard clinical diagnosis. Gonadotropins are normal here, and sex steroids are normal — this term is internally contradictory and does not apply. ## Gonadotropin Profile LH 8 mIU/mL and FSH 6 mIU/mL give an LH:FSH ratio of ~1.3:1. While a classic elevated LH:FSH ratio (>2:1) is often cited in PCOD, it is **not** part of the Rotterdam diagnostic criteria and its absence does not exclude PCOD. Many lean/mildly overweight PCOD patients have a normal or mildly elevated ratio (Harrison's Principles of Internal Medicine, 21st ed.; Williams Textbook of Endocrinology). ## Management Implications - **Lifestyle modification** remains first-line given weight gain and BMI 26 kg/m². - **Ovulation induction** with letrozole (preferred per ASRM 2023) or clomiphene citrate for infertility. - **Metformin** may be considered given metabolic risk profile. - Long-term monitoring for metabolic syndrome, type 2 diabetes, and endometrial hyperplasia. **Clinical Pearl:** PCOD is a diagnosis of exclusion requiring ≥2 Rotterdam criteria after ruling out thyroid dysfunction (TSH normal), hyperprolactinemia (prolactin normal), and non-classical CAH. This patient fulfills that diagnostic pathway. *(Rotterdam Consensus Workshop Group, Human Reproduction 2004; Williams Gynecology 4th ed.)*